# 2026年2月16日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 脑源性神经营养因子及其衍生的十二肽在急性肺损伤中作为Toll样受体4拮抗剂发挥作用

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41690930)
**期刊：** Nature communications
**PMID：** 41690930
**DOI：** 10.1038/s41467-026-69541-7

### 第一部分 原文与翻译

**英文原标题：** Brain-derived neurotrophic factor and the derived dodecapeptide function as Toll-like receptor 4 antagonists in acute lung injury.

> **英文摘要：**
> The neurotrophic factor (NTF) family has recently expanded its role beyond neurological conditions, but its involvement in acute inflammatory lung diseases remains largely unclear. Using well-established acute lung injury (ALI) and sepsis models, we demonstrate that brain-derived neurotrophic factor (BDNF), a key NTF, is impaired in pulmonary epithelial cells and negatively correlates with the inflammatory response. Raising the BDNF level alleviates inflammatory lung injury, but these effects are absent in macrophage-deleted mice. Both in vivo and in vitro results show BDNF inhibits macrophage inflammation, and further proteomics analysis identifies macrophage TLR4 as a receptor that BDNF antagonizes via direct binding. The BDNF fragment (aa 104-115) is critical for BDNF-TLR4 interaction, and the corresponding synthetic BDNF-derived dodecapeptide (BDP-12) retains TLR4-antagonistic and anti-inflammatory effects both in vitro and in vivo, without pro-proliferative side effects. In conclusion, our findings reveal that epithelial-derived BDNF prevents macrophage inflammation by directly targeting TLR4 and highlights BDP-12 as a potential therapeutic agent for acute inflammatory diseases.

> **中文摘要：**
> 神经营养因子（NTF）家族最近已将其作用扩展到神经系统疾病之外，但其在急性炎症性肺病中的参与情况在很大程度上仍不清楚。通过使用成熟的急性肺损伤（ALI）和脓毒症模型，我们证明了关键的NTF——脑源性神经营养因子（BDNF）在肺上皮细胞中表达受损，并与炎症反应呈负相关。提高BDNF水平可减轻炎症性肺损伤，但这些效应在巨噬细胞缺失的小鼠中消失。体内和体外结果均显示BDNF能抑制巨噬细胞炎症，进一步的蛋白质组学分析确定巨噬细胞TLR4是BDNF通过直接结合而拮抗的受体。BDNF片段（aa 104-115）对于BDNF-TLR4相互作用至关重要，且相应的合成BDNF衍生十二肽（BDP-12）在体内外均保留了TLR4拮抗和抗炎作用，且不产生促增殖的副作用。总之，我们的研究结果揭示了上皮来源的BDNF通过直接靶向TLR4来防止巨噬细胞炎症，并突出了BDP-12作为急性炎症性疾病潜在治疗药物的价值。

### 第二部分 AI 大师评价

本研究深入探讨了脑源性神经营养因子（BDNF）在非神经系统疾病中的跨界作用，揭示了肺上皮来源的BDNF在急性肺损伤中的保护机制。研究通过蛋白质组学和分子互作分析，明确了BDNF通过直接结合并拮抗TLR4受体来抑制巨噬细胞介导的炎症反应。其核心创新点在于识别了BDNF的关键功能片段并开发了无促增殖副作用的十二肽类似物BDP-12，为ALI和脓毒症等急性炎症性疾病提供了具有临床转化潜力的候选药物治疗策略。

---

## 2. 破伤风

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41544646)
**期刊：** Lancet (London, England)
**PMID：** 41544646
**DOI：** 10.1016/S0140-6736(25)01579-X

### 第一部分 原文与翻译

**英文原标题：** Tetanus.

> **英文摘要：**
> Tetanus, although preventable by a highly effective vaccine, continues to cause 30 000-50 000 deaths annually. Global mortality has fallen substantially since the 1980s due to widespread vaccination efforts, yet adult disease persists, especially among those with weakened immune response, diabetes, and people who inject drugs. Diagnosis is still clinical, and management combines wound debridement, antibiotics, and antitoxin. However, key questions about prevention, diagnosis, and management remain unanswered. Recent trials suggest human and equine antitoxin perform equally, but shortages and high costs persist. Autonomic instability, once thought a late stage complication, is now defined early in the disease course, affecting the prognosis. Due to patients being in intensive care, complications such as nosocomial infections can increase the burden of the disease, reinforcing that vaccination, surveillance, equitable access, and new therapy options are vital.

> **中文摘要：**
> 破伤风虽然可以通过高效疫苗预防，但每年仍导致 30,000 至 50,000 人死亡。自 20 世纪 80 年代以来，由于广泛的疫苗接种工作，全球死亡率大幅下降，但成人疾病依然存在，特别是在免疫反应减弱的人群、糖尿病患者和注射吸毒者中。诊断仍依靠临床表现，管理措施结合了伤口清创、抗生素和抗毒素。然而，关于预防、诊断和管理的关键问题仍未得到解答。最近的试验表明，人用和马源抗毒素的效果相当，但短缺和高成本的问题依然存在。自主神经不稳定曾被认为是晚期并发症，现在被定义为疾病早期的表现，并会影响预后。由于患者处于重症监护状态，院内感染等并发症会增加疾病负担，这进一步强调了疫苗接种、监测、公平获取以及新治疗选择至关重要。

### 第二部分 AI 大师评价

本文对破伤风的全球流行现状及临床挑战进行了深入探讨，指出在疫苗普及背景下，成人脆弱群体及特定职业人群仍面临较高风险。文章重点更新了自主神经不稳定在早期预后评估中的价值，并对比了不同来源抗毒素的效能，揭示了药物供应不均与高昂成本的现实困境。该综述为进一步完善破伤风的监测体系、优化重症监护管理以及推动全球医疗公平提供了重要的学术参考。

---

速递结束，祝您工作愉快！